SEC Form 4 · accession 0001179110-16-030831
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandra Poole
Officer — Executive VP, Tech Operations
Period of report
Oct 19, 2016
Accepted (ET)
Oct 20, 2016 · 11:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $2.26 | Oct 19, 2016 | A | 27,500 | A | Oct 19, 2017 | Oct 19, 2026 | Common stock | 27,500 | 27,500 | D |
Explanation of responses
- F1Exercisable as to 9,167 shares commencing on October 19, 2017, 9,167 shares commencing on October 19, 2018 and 9,166 shares commencing on October 19, 2019.